Latest news with #GoutEducationSociety
Yahoo
22-05-2025
- Health
- Yahoo
Gout Education Society promotes importance of "Crystal Clear" communication between patients and medical professionals
GAINESVILLE, Fla., May 22, 2025 /PRNewswire/ -- The Gout Education Society announces the launch of "Crystal Clear"—a campaign underscoring the importance of clarity for both patients and medical professionals related to gout diagnosis, treatment and management. The campaign officially kicks off May 22, 2025, Gout Awareness Day. Now in its nineteenth year, Gout Awareness Day is focused on educating the public about the risk factors and treatment options of this disease. Gout is an extremely painful and chronic form of inflammatory arthritis caused by elevated uric acid levels. Over time, uric acid can accumulate and form crystals in the joints and other tissues—leading to painful flares. Untreated, gout can lead to permanent bone, joint and tissue damage, and other serious health issues, including kidney disease, heart disease and diabetes. Not only is gout serious and extremely painful, it is also widely misunderstood by the public, yet, easily treated, according to N. Lawrence Edwards, MD, MACP, MACR, chairman of the Gout Education Society. "Gout is a debilitating condition that can significantly impact quality of life for patients and their families, explained Dr. Edwards. "It's vital for gout sufferers and their healthcare providers to have open, honest conversations about gout. In other words, they need to be "crystal clear" about symptoms, concerns and treatment options in order to help ensure the best possible patient journey and medical outcome." Formed in 2005, the Gout Education Society aims to improve the quality of care and minimize the burden of gout. A variety of complimentary resources for the public and medical professionals is available at The website also includes a portal for medical professionals, who can sign up to be a part of the Gout Specialists Network and help patients find qualified medical professionals not just by zip code, but also by areas of specialty. About the Gout Education Society The Gout Education Society (formerly The Gout & Uric Acid Education Society) is a 501 (c)(3) nonprofit organization formed in September 2005 by rheumatologists. The Gout Education Society is dedicated to educating the public and health care community about gout—the most common form of inflammatory arthritis—and helping to improve overall patient care. Website: Facebook: Gout Education X: @GoutEducation Media Contacts:Ian Amanda 717-917-0522 View original content to download multimedia: SOURCE Gout Education Society Sign in to access your portfolio
Yahoo
22-05-2025
- Health
- Yahoo
Gout Education Society promotes importance of "Crystal Clear" communication between patients and medical professionals
GAINESVILLE, Fla., May 22, 2025 /PRNewswire/ -- The Gout Education Society announces the launch of "Crystal Clear"—a campaign underscoring the importance of clarity for both patients and medical professionals related to gout diagnosis, treatment and management. The campaign officially kicks off May 22, 2025, Gout Awareness Day. Now in its nineteenth year, Gout Awareness Day is focused on educating the public about the risk factors and treatment options of this disease. Gout is an extremely painful and chronic form of inflammatory arthritis caused by elevated uric acid levels. Over time, uric acid can accumulate and form crystals in the joints and other tissues—leading to painful flares. Untreated, gout can lead to permanent bone, joint and tissue damage, and other serious health issues, including kidney disease, heart disease and diabetes. Not only is gout serious and extremely painful, it is also widely misunderstood by the public, yet, easily treated, according to N. Lawrence Edwards, MD, MACP, MACR, chairman of the Gout Education Society. "Gout is a debilitating condition that can significantly impact quality of life for patients and their families, explained Dr. Edwards. "It's vital for gout sufferers and their healthcare providers to have open, honest conversations about gout. In other words, they need to be "crystal clear" about symptoms, concerns and treatment options in order to help ensure the best possible patient journey and medical outcome." Formed in 2005, the Gout Education Society aims to improve the quality of care and minimize the burden of gout. A variety of complimentary resources for the public and medical professionals is available at The website also includes a portal for medical professionals, who can sign up to be a part of the Gout Specialists Network and help patients find qualified medical professionals not just by zip code, but also by areas of specialty. About the Gout Education Society The Gout Education Society (formerly The Gout & Uric Acid Education Society) is a 501 (c)(3) nonprofit organization formed in September 2005 by rheumatologists. The Gout Education Society is dedicated to educating the public and health care community about gout—the most common form of inflammatory arthritis—and helping to improve overall patient care. Website: Facebook: Gout Education X: @GoutEducation Media Contacts:Ian Amanda 717-917-0522 View original content to download multimedia: SOURCE Gout Education Society Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22-05-2025
- Health
- Yahoo
Atom Therapeutics Joins Gout Education Society on Gout Awareness Day, May 22, to Help Educate the Public on Risk Factors and Treatment Options for This Growing Disease
Atom's lead drug, lingdolinurad (ABP-671) is in Phase 2b/3 trials for chronic gout and hyperuricemia ZHEJIANG, China, May 22, 2025--(BUSINESS WIRE)--Gout is the most common form of inflammatory arthritis: More than 12 million Americans suffer from the disease, and this number continues to rise. But in addition to being prevalent, serious and extremely painful, gout is also widely misunderstood by the public. May 22 marks Gout Awareness Day—a day set aside each year since 2006 to educate on the severity of gout and encourage proper diagnosis and treatment. The need to keep this disease top-of-mind remains strong, notes N. Lawrence Edwards, MD, MACP, MACR, chairman of the non-profit Gout Education Society, which founded Gout Awareness Day 19 years ago. "Gout is a serious condition that can lead to permanent joint damage if left untreated. By raising awareness, we hope to encourage individuals to seek proper treatment and manage their condition effectively," he explained. "While this is a priority for the Gout Education Society each and every day, Gout Awareness Day enables us to join with like-minded individuals and organizations to advocate for better quality of life for patients and their families through education and awareness." Dr. William Shi, Founder, CEO and Chairman of Atom Therapeutics, which is developing new therapies to address gout, echoed Dr. Edwards' comments: "Over the last 30 years, the percentage of people developing gout has been steadily rising, yet many don't understand their disease. Furthermore, only one in three report taking their daily medications as prescribed to lower uric acid levels. We support the Gout Education Society's efforts to improve the quality of care and minimize the burden of gout." Gout is caused by elevated uric acid levels. Over time, uric acid can accumulate and form crystals in the joints and other tissues—leading to painful flares. Untreated, gout can lead to permanent bone, joint and tissue damage, and other serious health issues, including kidney disease, heart disease and diabetes. In conjunction with Gout Awareness Day, the Gout Education Society and Atom Therapeutics urge gout sufferers to learn more about the disease, seek immediate treatment and take ongoing steps to manage gout—with the most important step being to check uric acid levels every six months and aim for a healthy target of 6.0 mg/dL or below. While uric acid-lowering medications are typically needed to control gout and reduce future risks, those with gout should also make lifestyle changes—which includes following a healthy and balanced diet. About Atom Therapeutics Atom Therapeutics Ltd. is a fast-growing innovative drug company focused on the development of best in class small molecule therapeutics for treatment of inflammatory and metabolic diseases. The company's lead product, lingdolinurad (ABP-671), is in late-stage clinical development for treatment of chronic gout. Another small molecule ABP-745, for anti-inflammatory and autoimmune conditions, has completed Phase 1 clinical trials in the US and demonstrated good pharmacokinetics and safety, and has initiated Phase 2 clinical trial. For more information please visit: View source version on Contacts Media contactDaniel EramianOpus Biotech Communications425-306-8716
Business Wire
22-05-2025
- Health
- Business Wire
Atom Therapeutics Joins Gout Education Society on Gout Awareness Day, May 22, to Help Educate the Public on Risk Factors and Treatment Options for This Growing Disease
ZHEJIANG, China--(BUSINESS WIRE)--Gout is the most common form of inflammatory arthritis: More than 12 million Americans suffer from the disease, and this number continues to rise. But in addition to being prevalent, serious and extremely painful, gout is also widely misunderstood by the public. May 22 marks Gout Awareness Day—a day set aside each year since 2006 to educate on the severity of gout and encourage proper diagnosis and treatment. The need to keep this disease top-of-mind remains strong, notes N. Lawrence Edwards, MD, MACP, MACR, chairman of the non-profit Gout Education Society, which founded Gout Awareness Day 19 years ago. "Gout is a serious condition that can lead to permanent joint damage if left untreated. By raising awareness, we hope to encourage individuals to seek proper treatment and manage their condition effectively,' he explained. 'While this is a priority for the Gout Education Society each and every day, Gout Awareness Day enables us to join with like-minded individuals and organizations to advocate for better quality of life for patients and their families through education and awareness.' Dr. William Shi, Founder, CEO and Chairman of Atom Therapeutics, which is developing new therapies to address gout, echoed Dr. Edwards' comments: 'Over the last 30 years, the percentage of people developing gout has been steadily rising, yet many don't understand their disease. Furthermore, only one in three report taking their daily medications as prescribed to lower uric acid levels. We support the Gout Education Society's efforts to improve the quality of care and minimize the burden of gout.' Gout is caused by elevated uric acid levels. Over time, uric acid can accumulate and form crystals in the joints and other tissues—leading to painful flares. Untreated, gout can lead to permanent bone, joint and tissue damage, and other serious health issues, including kidney disease, heart disease and diabetes. In conjunction with Gout Awareness Day, the Gout Education Society and Atom Therapeutics urge gout sufferers to learn more about the disease, seek immediate treatment and take ongoing steps to manage gout—with the most important step being to check uric acid levels every six months and aim for a healthy target of 6.0 mg/dL or below. While uric acid-lowering medications are typically needed to control gout and reduce future risks, those with gout should also make lifestyle changes—which includes following a healthy and balanced diet. About Atom Therapeutics Atom Therapeutics Ltd. is a fast-growing innovative drug company focused on the development of best in class small molecule therapeutics for treatment of inflammatory and metabolic diseases. The company's lead product, lingdolinurad (ABP-671), is in late-stage clinical development for treatment of chronic gout. Another small molecule ABP-745, for anti-inflammatory and autoimmune conditions, has completed Phase 1 clinical trials in the US and demonstrated good pharmacokinetics and safety, and has initiated Phase 2 clinical trial. For more information please visit:
